The Cell Culture Media And Reagents Market is being driven by Advancements in life science industry
The Cell Culture Media And Reagents Market is expected to grow at a CAGR of 8.11% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 5165.4 million. In the realm of cell culture, this technique is utilized extensively to cultivate and preserve diverse cell types in a controlled laboratory environment, mirroring complex human disease conditions such as cancerous tumors. The cell culture media and reagents market is undergoing a significant transformation, with a growing preference towards serum-free supplements over traditional serum-based media like FBS and fetal calf serum (FCS). The rationale behind this shift is rooted in the potential contamination risks posed by serum-based media due to their higher protein concentrations exceeding the protein requirements for optimal mammalian cell growth. Moreover, the unpredictable composition of naturally occurring components in serum-based media poses a challenge for researchers in accurately quantifying the necessary protein content for optimal cell expansion.
Get more information on Cell Culture Media And Reagents Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
173 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.11% |
Market growth 2024-2028 |
USD 5165.4 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
8.02 |
Key countries |
US, Japan, China, Canada, Germany, UK, France, India, South Korea, UAE, Brazil, US, Japan, China, Canada, and Germany |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Cell Culture Media and Reagents Market encompasses a range of products essential for cell growth and manipulation in laboratories and industrial-scale production. Key offerings include cell culture flasks, multi-well plates, and dishes, as well as CO2 incubators for optimal growth conditions. Additional tools include cell counters, flow cytometry, and imaging systems for cell analysis. Single-use bioreactors and bioprocessing equipment facilitate large-scale cell production. Quality assurance and regulatory compliance are ensured through microbial contamination control and adherence to biopharmaceutical manufacturing standards. Applications span drug development, clinical trials, therapeutic antibodies, gene therapy, personalized medicine, biosimilar development, and biosimilar characterization.
In the context of the global pharmaceuticals market, the sector encompasses businesses involved in the research and development (R&D) or production of various drug categories, including generic, non-generic, and veterinary drugs. According to Technavio's market analysis, the healthcare industry size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the growth of the pharmaceuticals market include the increasing aging population, with predictions suggesting that by 2050, approximately one-quarter of the US population and by 2030 in Europe will be over 60 years old. This demographic shift is anticipated to significantly boost the demand for cell culture media, growth media, basal media, and related products essential for drug production.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted